La cadena de opciones muestra datos clave de las opciones de acciones de Biodesix a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Biodesix..

Biodesix (NASDAQ:BDSX) Bolsa, Cadena de Opciones

Biodesix

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Biodesix Inc

<ul>
<li>The AI-focused event, held at the Company's Los Angeles headquarters, consisted of AI experts, panel guests, potential future AI talents and FF employees, and showcased the Company's current and future AI strategy developments.</li>
<li>The new ‘Future AIHER' subsidiary is dedicated to the commercialization and development of both AI extended range and AI hybrid extended-range electric powertrain systems and solutions for both FF and potential future FX models and to other automotive OEMs, as well as air, ground, and ocean applications, such as electric vertical takeoff and landing (EVTOL) aircraft, commercial trucking, and electric boating industries.</li>
<li>FF and FX could offer up to three different powertrain systems: battery electric, range extended, and a super AI hybrid extended-range system designed specifically for U.S. consumers.</li>
</ul>

News

Faraday Future Intelligent Electric Inc. - Class A Common Stock

FFAI

Faraday Future Expands EV Innovation With Formation Of Future AIHER Subsidiary And Debuts AI Strategy at Company's First Open AI Day

EsoBiotec will become a wholly owned subsidiary of AstraZeneca, with operations in Belgium.
AstraZeneca will acquire all outstanding equity of EsoBiotec for a total consideration of up to $1,000m, on a cash and debt free basis. This will include an initial payment of $425m on deal closing, and up to $575m in contingent consideration based on development and regulatory milestones.
The transaction is expected to close in the second quarter of 2025, subject to customary closing conditions and regulatory clearances.

AstraZeneca To Acquire EsoBiotec For Up To $1B, Advancing In Vivo Cell Therapy Capabilities With Breakthrough ENaBL Platform

Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) is reportedly entering its annual Top 100 executive retreat this week. This comes amid <a href="https://in.benzinga.com/media/25/03/44207932/apple-delays-next-gen-siri-its-going-to-take-us-longer-than-we-thought-to-deliver-ai-upgrades">mounting criticism over</a> the company's stalled artificial intelligence efforts.
What Happened: Since the era of Steve Jobs, this annual March gathering brings together Apple&#8217;s 100 most influential executives, reported Bloomberg's Mark Gurman in his latest weekly "Power On" newsletter.&nbsp;&nbsp;
He also called out top executives including CEO Tim Cook, marketing heads Greg Joswiak and Bob Borchers, software chief Craig Federighi, and AI lead John Giannandrea, saying all share <a href="https://www.benzinga.com/tech/25/03/44068020/apples-ai-crisis-falling-behind-in-the-ai-race">blame for the failure to deliver</a>.
See Also:&nbsp;<a href="https://www.benzinga.com/25/03/44069535/anthropic-ceo-dario-amodei-pushes-for-stronger-us-ai-safeguards-saying-autocracies-like-china-and-russia-could-use-ai-to-expand-their-power" target="_blank" rel="noreferrer noopener">Jeff Bezos-Backed Anthropic Pushes For Stronger US AI Safeguards, Saying Autocracies Like China, Russia Could Use AI To Expand Their Power</a>
&#8220;Given the nature of this collective failure, it's unlikely to result in management changes on Cook's executive team. That would mean admitting fault, which Apple hates doing,&#8221; Gurman said.
Previously, it was reported that Apple's Siri chief Robby Walker <a href="https://in.benzinga.com/25/03/44345486/apple-scrambles-to-fix-siris-ugly-and-embarrassing-ai-failures-after-public-missteptop-executive-admits-marketing-it-too-soon-made-things-worse">described the situation</a> as embarrassing, ugly and disappointing, blaming the early marketing push for features that weren't ready.
Subscribe to the <a href="https://bztechtrends.beehiiv.com/subscribe">Benzinga Tech Trends newsletter</a> to get all the latest tech developments delivered to your inbox.
Why It's Important: Apple's <a href="https://www.benzinga.com/news/24/07/39665558/apples-most-awaited-siri-ai-upgrade-will-not-come-until-2025-report">long-promised Apple Intelligence</a> — including major upgrades to Siri — is in disarray, with features delayed indefinitely and internal frustration mounting.&nbsp;
Apple is under growing pressure to catch up in the AI race as rivals like OpenAI, Alphabet Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google, Meta Platforms, Inc. (NASDAQ:&nbsp; META), Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) and Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) advance rapidly.
Apple&#8217;s AI setbacks coincide with a 12.45% drop in its stock value this year. Last week, Morgan Stanley expressed concerns about the company&#8217;s AI delays, lowering its <a href="https://in.benzinga.com/analyst-ratings/analyst-color/25/03/44284821/apple-stock-takes-a-bite-out-of-investors-as-siri-fumbles-ai-race">price target from $275 to $252</a>.
Price Action: Apple shares ended Friday at $213.49, gaining 1.82% during the session. However, in after-hours trading, the stock dipped slightly by 0.07%, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.
Image via Shutterstock
Check out more of Benzinga's Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/legal/25/03/44344993/apple-reportedly-fights-uk-governments-unacceptable-encryption-order-behind-closed-doors-no-press-or-public-allowed" target="_blank" rel="noreferrer noopener">Apple Reportedly Fights UK Government's ‘Unacceptable' Encryption Order Behind Closed Doors — No Press Or Public Allowed</a></li>
</ul>

Tech

Media

AAPL

AMZN

GOOG

GOOGL

MSFT

Apple's AI Crisis Reaches Boiling Point Ahead Of Top 100 Executive Retreat — Tim Cook And Key Execs Called Out Over Siri Failure By Top Analyst

<ul>
<li>Final data analysis from Phase 3 MIRASOL trial after 30.5-month median follow-up demonstrated 32% reduction in risk of death with ELAHERE compared to chemotherapy in folate receptor alpha (FRα)-positive platinum-resistant ovarian cancer (PROC)
<ul>
<li>Data presented in a late-breaking oral presentation at the Society of Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer in Seattle</li>
</ul>
</li>
</ul>

ABBV

Reported Saturday, AbbVie Highlights Final MIRASOL Results At SGO 2025 Showing Clinically Meaningful Survival Gains With ELAHERE In Platinum-Resistant Ovarian Cancer

Berkshire Hathaway Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) led by the Oracle of Omaha, Warren Buffett, is in <a href="https://www.benzinga.com/ma/25/03/44317138/warren-buffetts-real-estate-brokerage-compass-discuss-deal-report">talks to sell</a> its real estate brokerage business to New York-based Compass Real Estate. While some experts view this as his levered bet against the U.S. home prices, others see it as a consolidation in the realty sector.
What Happened: Compass has offered to buy Berkshire&#8217;s realty business, HomeServices of America, including Real Living, for an undisclosed price, according to a WSJ <a href="https://www.wsj.com/real-estate/compass-in-talks-to-buy-warren-buffetts-real-estate-brokerage-unit-5eab82e5">report</a>. The Berkshire business has about 820 offices and 270 franchises, whereas Compass is the second-largest U.S. brokerage.
After these reports emerged, billionaire investor Chamath Palihapitiya took to X and said that &#8220;The world's best investor is selling his bet levered to US home prices.&#8221;
However, there wasn&#8217;t a consensus on the fact that a bet against a traditional brokerage is the same as betting against the U.S. home prices. According to Amy Nixon, a DFW housing and economic analyst, the possible sale of Berkshire&#8217;s realty business to Compass was &#8220;not necessarily a bet against US home prices,&#8221; because Buffett could be betting on the real estate technology to reshape the industry further.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">He dumped all his home builder stocks a year ago and that proved wise That said, a bet against a traditional brokerage is not necessarily a bet against US home prices He may be betting on REtech reshaping the industry even further
&mdash; Amy Nixon (@texasrunnerDFW) <a href="https://twitter.com/texasrunnerDFW/status/1901335669978390537?ref_src=twsrc%5Etfw">March 16, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/25/03/44298732/nvidia-valuation-drops-after-2025-rout-ai-chipmakers-price-declines-41-from-its-peak-when-chatgpt-was-launched">Nvidia Valuation Drops After 2025 Rout: Chipmaker&#8217;s Price Declines 41% From Its Peak When ChatGPT Was Launched</a>
Why It Matters: Despite a sale of its business having any correlation with a bet on U.S. home prices, as mentioned by Nixon. The impact of higher interest rates does affect the housing market. Higher interest rates strain both homebuyers, facing increased monthly payments, and sellers, experiencing reduced demand and lower offers.
The Federal Reserve&#8217;s primary monetary policy-making body, the Federal Open Market Committee, is scheduled to meet on March 18 and 19 this week to decide on the course of interest rates.
According to the CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>, there is a 99% chance that the Federal Reserve will keep interest rates unchanged for the March meeting. However, the probability of an ease increases from June 2025 onwards. 
Furthermore, the U.S. real estate sector is consolidating, as Rocket Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RKT#NYSE">RKT</a>) signed an <a href="https://www.benzinga.com/ma/25/03/44317138/warren-buffetts-real-estate-brokerage-compass-discuss-deal-report">acquisition deal</a> worth $1.75 billion last week with Redfin Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDFN#NASDAQ">RDFN</a>).
Price Action: The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, rose on Friday. The SPY was advanced 2.07% to $562.81, and the QQQ also jumped 2.42% to $479.66, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/03/44299872/jack-dorseys-block-first-us-company-to-deploy-nvidias-ai-cluster-predicts-30x-performance-boost">Jack Dorsey&#8217;s Block First US Company To Deploy Nvidia&#8217;s AI Cluster, Predicts 30x Performance Boost</a></li>
</ul>
Photo courtesy: Shutterstock

Markets

RDFN

Warren Buffett Plans To Sell His Real Estate Brokerage, But It's 'Not… A Bet Against US Home Prices,' Says Analyst As Fed Expects To Keep Rates Unchanged

RKLB

Reported Saturday, Rocket Lab Successfully Deploys Third Pioneer Spacecraft To Orbit, Powering Varda's Latest In-Space Pharmaceutical Manufacturing Mission

<ul>
<li>Azenosertib median duration of response (mDOR) updated to 6.3 months in the ongoing DENALI Part 1b clinical trial in patients with platinum-resistant ovarian cancer (PROC) and continues to demonstrate an objective response rate (ORR) of ~35% in response-evaluable patients</li>
<li>On track to initiate Part 2 of the ongoing DENALI clinical trial in 1H 2025, with registration-intent topline data anticipated by year end 2026</li>
<li>Company also presents preclinical combination data of azenosertib with microtubule inhibitor-based antibody-drug conjugates (ADCs), demonstrating synergistic antitumor effects</li>
</ul>

ZNTL

Reported Saturday, Zentalis Presented Updated DENALI Part 1b Clinical Data Demonstrating 6.3-Month mDOR And ~35% ORR With Azenosertib Monotherapy In Cyclin E1+ Platinum-Resistant Ovarian Cancer

SpaceX CEO Elon Musk hinted at a possible timeline for human landings on Mars.
What Happened: On Saturday, Musk posted on X that SpaceX&#8217;s Starship is scheduled to depart for Mars by the end of 2026, carrying Tesla Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) Optimus robot. He indicated that if the landings go well, human missions could start as early as 2029, although 2031 seems more probable.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Starship departs for Mars at the end of next year, carrying Optimus. If those landings go well, then human landings may start as soon as 2029, although 2031 is more likely. <a href="https://t.co/JRBB95sgNN">https://t.co/JRBB95sgNN</a>
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1900774290682683612?ref_src=twsrc%5Etfw">March 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The post comes in the wake of SpaceX&#8217;s 23rd anniversary,&nbsp;celebrated on March 14.&nbsp;The reference to Optimus is notable as it connects to Tesla&#8217;s humanoid robot development, initially revealed in 2021, designed for tasks both on Earth and in space. Musk anticipates their involvement in Mars exploration as early as 2026.
SEE ALSO: <a href="https://www.benzinga.com/markets/equities/25/03/44349818/warren-buffett-dumped-nearly-70-of-apple-shares-but-its-price-to-sales-ratio-remains-elevated-at-8-2x-warns-this-market-analyst">Warren Buffett Dumped Nearly 70% Of Apple Shares, But Its Price-To-Sales Ratio Remains Elevated At 8.2x, Warns This Market Analyst</a>
Why It Matters: Musk&#8217;s post aligns with his long-term vision for human settlement on Mars, with potential missions beginning in 2029 or 2031, according to recent updates. In February, Musk also mentioned that <a href="https://www.benzinga.com/general/space/25/02/43840887/spacex-ceo-elon-musk-says-making-mars-self-sustaining-will-take-up-to-half-a-century-will-require-10-earth-mars-transfer-windows">making Mars self-sustaining</a> or capable of supporting human life will take somewhere between 25-50 years. 
In a Reuters report in November, sources familiar with U.S. President Donald Trump&#8217;s space policy agenda revealed to the publication that Elon Musk&#8217;s vision of human transportation to Mars is set to become a greater national priority under the President. &#8220;We want to reach Mars before the end of my term,&#8221; Trump said during his 2024 presidential campaign. He had even set up the Space Force and revived the National Space Council during his previous term.
George Nield, president of Commercial Space Technologies and a former FAA official had told AFP in November, &#8220;There&#8217;s a good chance we&#8217;ll see at least a re-look at the Artemis program—whether that means speeding it up or even skipping the moon to focus on Mars.&#8221;&nbsp;This could be a monumental change for a program estimated to cost over $90 billion.
On Friday, SpaceX&#8217;s Falcon 9 rocket lifted off, carrying a crew to the International Space Station (ISS) as part of a mission to <a href="https://www.benzinga.com/25/03/44344973/nasa-spacex-one-step-closer-to-bring-back-astronauts-butch-wilmore-sunita-williams-stranded-due-to-boeings-starliner-issues-replacement-crew-launches-successfully">return two astronauts</a>, Butch Wilmore and Sunita Williams, back to the U.S.
READ MORE:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44349867/bitcoin-dogecoin-were-muffled-last-week-but-telegrams-pavel-durov-getting-his-passport-back-gave-toncoin-its-wings">Bitcoin, Dogecoin Were Muffled Last Week But Telegram&#8217;s Pavel Durov Getting His Passport Back Gave Toncoin Its Wings</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

SPACE

TSLA

Elon Musk Confirms Starship To Carry Tesla Optimus To Mars by 2026, Predicts Human Landing By 2029

Late-Breaking Oral Presentation Highlights:
<ul>
<li>At the selected optimized dose (5.2 mg/kg), luvelta achieved an ORR of 32%1 and a disease control rate (DCR) of 96% compared to an ORR of 13.8% and a DCR of 69% for the 4.3 mg/kg group.</li>
<li>The demonstrated clinical activity in the 5.2 mg/kg group was consistent in patients across all levels of FRα expression of 25% or greater, with an ORR of 30.8% and a DCR of 100% for positive staining (PS) 2+ ≥75% (eligible for approved FRα-targeting ADC) and an ORR of 33.3%1 and DCR of 91.7%1 for PS2+ &lt; 75%.</li>
<li>Safety was consistent across dosing groups, with no new safety signals observed and neutropenia well-managed.</li>
<li>The majority of patients across both dose cohorts received prior bevacizumab.</li>
</ul>

STRO

Reported Saturday, Sutro Highlights Late-Breaking Refrαme-O1 Data Demonstrating 32% ORR And 96% DCR With Optimized Luvelta Dosing In PROC Patients

<ul>
<li>Partnership will deliver revolutionary, emissions-free travel in the UK, including greater connectivity for Virgin Atlantic customers traveling to and from the airport</li>
<li>Virgin Atlantic to support Joby's preparations for operation in the UK</li>
<li>Agreement builds on Virgin Atlantic's track record of innovation and award-winning customer service</li>
</ul>

JOBY

Reported Saturday, Joby Aviation Partners With Virgin Atlantic To Launch All-Electric Air Taxi Service For Seamless Airport Connectivity In the UK

Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) investor Ross Gerber shared footage of protesters outside a Tesla store in Santa Monica, highlighting growing public backlash against the electric vehicle maker amid CEO Elon Musk&#8216;s political activities.
What Happened: &#8220;Guess the Tesla takeover was in Santa Monica today. My wife ran into this peaceful display of distaste for Elon Musk in front of the Tesla store,&#8221; Gerber wrote Sunday on X. The video concludes with the voice of his 9-year-old child saying, &#8220;I&#8217;m glad we don&#8217;t have a Tesla.&#8221;
Gerber, CEO of Gerber Kawasaki Wealth and Investment Management, has grown increasingly critical of Tesla despite his long-standing investment in the company. In a recent interview, he stated <a href="https://in.benzinga.com/25/03/44321998/why-ross-gerber-finds-tesla-stock-expensive-despite-its-50-plunge-fundamental-story-has-to-be-revalued">Tesla shares remain overvalued</a> even after plunging nearly 50% since mid-December.
&#8220;There&#8217;s this game that is happening now where the fundamental story has to be revalued,&#8221; Gerber said, noting Tesla&#8217;s forward price-to-earnings ratio of 65 remains more than triple the S&amp;P 500 average.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Guess the tesla takeover was in Santa Monica today. My wife ran into this peaceful display of distaste for Elon Musk in front of the tesla store. At the end listen to what my 9 year old said. Sad for tesla &#x1f61e; <a href="https://twitter.com/search?q=%24tsla&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$tsla</a> <a href="https://t.co/AXJXoX1fcP">pic.twitter.com/AXJXoX1fcP</a>
&mdash; Ross Gerber (@GerberKawasaki) <a href="https://twitter.com/GerberKawasaki/status/1901070393013924104?ref_src=twsrc%5Etfw">March 16, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/markets/equities/25/03/44349240/googles-waymo-leads-robotaxi-race-with-2-millon-paid-rides-zoox-challenges-tesla-for-second-spot-as-unsupervised-autonomy-becomes-table-stakes-says-gary-black">Google&#8217;s Waymo Leads Robotaxi Race With 2 Millon Paid Rides, Amazon&#8217;s Zoox Challenges Tesla For Second Spot As Autonomy Becomes &#8216;Table Stakes,&#8217; Says Gary Black</a>
Why It Matters: The protests come amid escalating tensions surrounding Musk&#8217;s dual role as Tesla CEO and leader of the Department of Government Efficiency in President Donald Trump&#8216;s administration. Demonstrations have <a href="https://in.benzinga.com/news/24/11/42028821/amazon-india-to-shift-headquarters-to-bengalurus-outskirts-to-cut-costs">occurred at Tesla showrooms</a> across the U.S., with Rep. Marjorie Taylor Greene (R-Ga.) recently calling for an FBI investigation into what she termed &#8220;organized attacks&#8221; on Tesla facilities.
Gerber previously indicated he would &#8220;eventually&#8221; sell his Cybertruck, <a href="https://in.benzinga.com/markets/equities/25/02/43761581/ross-gerber-says-hes-eventually-selling-his-cybertruck-because-the-hate-is-real-as-protests-rock-tesla-showrooms">writing in February</a> that &#8220;the hate is real&#8221; after spotting a vandalized vehicle. Public figures like singer Sheryl Crow have publicly documented selling their Teslas over political disagreements with Musk.
Tesla&#8217;s challenges extend internationally, with German sales <a href="https://www.benzinga.com/25/03/44295808/tesla-braces-for-lowest-quarterly-deliveries-since-2022-jpmorgan-predicts-a-brand-has-lost-so-much-value-so-quickly">reportedly dropping 60% year-over-year in January</a> following Musk&#8217;s support for far-right political groups. JPMorgan Chase analysts warned Wednesday that Tesla &#8220;lost too much brand value too quickly&#8221; and could face its lowest quarterly deliveries since 2022.
The company reported its first-ever annual sales decline in 2024, though Musk pledged Tuesday that Tesla would double its U.S. vehicle production over <a href="https://www.benzinga.com/markets/25/03/44346423/teslas-biggest-bull-frustrated-with-elon-musks-focus-on-doge-over-company-patience-wearing-thin">the next two years</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44348859/trump-says-he-was-little-bit-sarcastic-when-he-said-he-would-end-the-russia-ukraine-war-in-a-day-what-i-really-mean-is" target="_blank" rel="noreferrer noopener">Trump Says He Was ‘Little Bit Sarcastic' When He Said He Would End The Russia-Ukraine War In A Day: ‘What I Really Mean Is…'</a></li>
</ul>
Image Via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Ross Gerber Shares 'Peaceful Display Of Distaste For Elon Musk' In Santa Monica, His 9-Year Old Observes, 'Glad We Don't Have A Tesla'

Macro Economic Events

Econ #s

Economics

INDA

India Wholesale Price Index (WPI) Inflation (YoY) For February 2.38% Vs. 2.36% Est.; 2.31% Prior

Reported Saturday, CenterPoint Energy Reports Strong System Performance And Minimal Outages As Red Flag Weather Conditions Ease In Greater Houston

<ul>
<li>With the launch of ERNIE 4.5 and ERNIE X1, ERNIE Bot is made free to the public ahead of schedule, and users can access both models free of charge.</li>
<li>As a deep-thinking reasoning model with multimodal capabilities, ERNIE X1 delivers performance on par with DeepSeek R1 at only half the price.</li>
<li>ERNIE 4.5 is the company's latest foundation model and native multimodal model, with input and output prices starting as low as RMB 0.004 per thousand tokens and RMB 0.016 per thousand tokens.</li>
</ul>

BIDU

Reported Earlier, Baidu Introduces ERNIE 4.5 And Deep-Thinking Model ERNIE X1 With Advanced Multimodal Reasoning

With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects Science Applications International Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIC#NASDAQ">SAIC</a>) to report quarterly earnings at $2.08 per share on revenue of $1.81 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Science Applications International shares gained 0.2% to close at $104.43 on Friday.</li>
<li>Analysts are expecting Getty Images Holding Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GETY#NYSE">GETY</a>) to post quarterly earnings at 4 cents per share on revenue of $246.31 million. The company will release earnings after the markets close. Getty Images shares rose 2% to close at $2.04 on Friday.</li>
<li>Castellum Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTM#NYSE">CTM</a>) reported a proposed public offering of common stock and warrants. Castellum shares tumbled 22.9% to $0.9101 in pre-market trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>After the closing bell, Consolidated Water Co. Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CWCO#NASDAQ">CWCO</a>) is projected to report quarterly earnings at 28 cents per share on revenue of $33.60 million. Consolidated Water shares gained 2.8% to close at $29.18 on Friday.</li>
<li>Analysts expect Townsquare Media Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSQ#NYSE">TSQ</a>) to post quarterly earnings at 60 cents per share on revenue of $116.41 million before the opening bell. Townsquare Media shares rose 1.9% to $7.94 in after-hours trading.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44326690/top-3-materials-stocks-that-may-collapse-in-march">Top 3 Materials Stocks That May Collapse In March</a></li>
</ul>
Photo courtesy: Shutterstock

Earnings

Pre-Market Outlook

Trading Ideas

CWCO

GETY

SAIC

Science Applications International, Getty Images And 3 Stocks To Watch Heading Into Monday

The CNN Money Fear and Greed index showed an improvement in the overall market sentiment, while the index remained in the &#8220;Extreme Fear&#8221; zone on Friday.
U.S. stocks settled higher on Friday, with the S&amp;P 500 surging more than 2% during the session.
Big tech shares fell sharply last week and saw a sharp recovery on Friday. Shares of Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) jumped more than 5%, while Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) added around 4% during the session.
Despite Friday's gains, stocks recorded losses last week. The Dow dipped around 3.1% to record its worst week since March 2023. The S&amp;P 500 dipped over 2%, recording its fourth straight losing week.
On the economic data front, the University of Michigan consumer sentiment dipped to 57.9 in March, recording the lowest reading since November 2022, compared to 64.7 in the previous month and down from market estimates of 63.1.
All sectors on the S&amp;P 500 closed on a positive note, with information technology, energy, and financial stocks recording the biggest gains on Friday.
The Dow Jones closed higher by around 675 points to 41,488.19 on Friday. The S&amp;P 500 rose 2.13% to 5,638.94, while the Nasdaq Composite climbed 2.61% at 17,754.09 during Friday's session.
Investors are awaiting earnings results from Science Applications International Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIC#NASDAQ">SAIC</a>), Getty Images Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GETY#NYSE">GETY</a>) and Consolidated Water Co. Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CWCO#NASDAQ">CWCO</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 21, the index remained in the &#8220;Extreme Fear&#8221; zone on Friday, versus a prior reading of 16.1.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44326690/top-3-materials-stocks-that-may-collapse-in-march">Top 3 Materials Stocks That May Collapse In March</a></li>
</ul>
Photo courtesy: Shutterstock

NVDA

S&P Jumps Over 2%, But Records Weekly Loss: Investor Fear Eases, Greed Index Remains In 'Extreme Fear' Zone

Business Outlook
As macro-economic uncertainties persist, the Company intends to maintain a prudent approach in its business planning for 2025. Management will continue to focus on enhancing efficiency of the Company's operations. As such, for the first quarter of 2025, the Company expects to generate a net income between RMB1.75 billion and RMB1.85 billion and a non-GAAP net income&#x2A;13 between RMB1.80 billion and RMB1.90 billion, representing a year-on-year growth between 49% and 58%. This outlook reflects the Company's current and preliminary views, which is subject to material changes.

Guidance

QFIN

Qifu Technology Q1 Outlook: Expects Net Income Of RMB1.75B–RMB1.85B And Non-GAAP Net Income Of RMB1.80B-RMB1.90B

Semi-Annual Dividend for the Second Half of 2024
The board of directors of the Company (the "Board") has approved a dividend of US$0.35 per Class A ordinary share, or US$0.70 per ADS for the second half of 2024 to holders of record of Class A ordinary shares and ADSs as of the close of business on April 23, 2025 Hong Kong Time and New York Time, respectively, in accordance with the Company's dividend policy. For holder of Class A ordinary shares, in order to qualify for the dividend, all valid documents for the transfers of shares accompanied by the relevant share certificates must be lodged for registration with the Company's Hong Kong branch share registrar, Computershare Hong Kong Investor Services Limited, at Shops 1712-1716, 17th Floor, Hopewell Centre, 183 Queen's Road East, Hong Kong no later than 4:30 p.m. on April 23, 2025 (Hong Kong Time). The payment date is expected to be on May 28, 2025 for holders of Class A ordinary shares and around June 2, 2025 for holders of ADSs

Dividends

Qifu Technology Raises Semi-Annual Dividend To $0.70 Per ADS From $0.60, Payable June 2; And $0.35 Per Class A Share Payable May 28

Qifu Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QFIN#NASDAQ">QFIN</a>) reported quarterly earnings of RMB13.66 per share which beat the analyst consensus estimate of RMB12.23 by 11.69 percent. This is a 91.32 percent increase over earnings of RMB7.14 per share from the same period last year. The company reported quarterly sales of RMB4.48 billion which beat the analyst consensus estimate of RMB4.25 billion by 5.53 percent. This is a 0.29 percent decrease over sales of RMB4.50 billion the same period last year.

Earnings Beats

Qifu Technology Q4 2024 Adj EPS RMB13.66 Beats RMB12.23 Estimate, Sales RMB4.48B Beat RMB4.25B Estimate

- Continued favorable safety profile for DYNE-251 -
- DELIVER Registrational Expansion Cohort is fully enrolled;&nbsp;data from this cohort planned for late 2025 -
- Potential for Biologics License Application submission for U.S. accelerated approval&nbsp;in early 2026 -

Reported Earlier, Dyne Therapeutics Phase 1/2 Trial Update Highlights Sustained Functional Improvement In Duchenne Muscular Dystrophy With Exon 51-Skipping Candidate; Regulatory Submission Targeted For Early 2026

Press Releases

Biodesix to Present at Two Investor Conferences in September

Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study

Biodesix to Report Third Quarter 2024 Financial Results on November 1, 2024

Biodesix to Participate in Three Investor Conferences in November

Biodesix Announces Third Quarter 2024 Results and Highlights

Health Care

Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study

Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited)

Biodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Biodesix to Present at TD Cowen 45th Annual Health Care Conference

Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results

BDSX

AirSculpt Technologies, Inc. - Common Stock

AirSculpt Technologies

American Shared Hospital Services Common Stock

American Shared Hospital

Cryo-Cell International, Inc. Common Stock

Cryo-Cell International

Concord Medical Services Holdings Limited American Depositary Shares (Each represents thirty (30) Class A ordinary shares)

Concord Medical Services

Cross Country Healthcare, Inc. - Common Stock

Cross Country Healthcare

DocGo

Enhabit

Enzo Biochem, Inc. Common Stock ($0.01 Par Value)

Enzo Biochem

Euda Health Holdings Limited - Ordinary Shares

EUDA Health Holdings

Fulgent Genetics

InnovAge Holding

Kindly MD

23andMe Holding

Mobile-health Network Solutions - Class A Ordinary Shares

Mobile-health Network

ModivCare

National Research Corporation - Common Stock

National Research

Nutex Health

Ontrak

Performant Healthcare, Inc. - Common Stock

Performant Healthcare

P3 Health Partners Inc. - Class A Common Stock

P3 Health Partners

Prenetics Global Limited - Class A Ordinary Share

Prenetics Global

Precipio

SHL Telemedicine Ltd - American Depositary Shares

Comments

Biodesix

Biodesix (BDSX) Opciones

Biodesix (NASDAQ:BDSX) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL